Results 161 to 170 of about 27,592 (211)

Formulation Strategies for Ezetimibe and Its Combinations: Advancing Biopharmaceutical and Therapeutic Potential. [PDF]

Drug Des Devel Ther
Priani SE, Chaerunisaa AY, Wilar G, Sopyan I.   +3 more
europepmc   +1 more source

Evaluation of bempedoic acid in elderly patients: real-world evidence from the REALIST study. [PDF]

Front Aging
Muscoli S, Di Marco E, Puttini F, Sposini Ghezzi S, Ifrim M, Amtaeh M, Renga EM, Cappello C, Barone G, Chiricolo G, Sangiorgi GM, Natale A, Della-Morte D.   +12 more
europepmc   +1 more source

Inclisiran in Dyslipidemia with High Residual Platelet Reactivity. [PDF]

Diseases
Kapsultanova D, Zhangelova S, Nurmukhammad F, Makasheva Z, Sakhov O, Galkina T, Rustamova F, Akhmentayeva D, Aubakirova B.   +8 more
europepmc   +1 more source

Consequences of Late Diagnosis and Insufficient Cholesterol Treatment in Women With Heterozygous Familial Hypercholesterolemia. [PDF]

JACC Case Rep
Santos RD.
europepmc   +1 more source

Efficacy and safety of switching to ezetimibe 10 mg/rosuvastatin 2.5 mg in Korean patients with type 2 diabetes mellitus and dyslipidaemia: A multicentre, prospective study (EROICA study). [PDF]

Diabetes Obes Metab
Hong S, Kim WJ, Kim S, Park JH, Kang ES, Moon MK, Kim JT, Mok JO, Lee KY, Park CY, Lee CB.   +10 more
europepmc   +1 more source

FDG-PET/CT of Achilles Tendon Xanthoma: A Hot Take on Imaging in Familial Hypercholesterolemia. [PDF]

JACC Case Rep
Kramer AI, Brunham LR.
europepmc   +1 more source

Familial Hypercholesterolaemia and the Risk of Cardiovascular Events. [PDF]

Cureus
Conchinha A, Rodrigues A, Pack T, Cunha S, Santos A.   +4 more
europepmc   +1 more source

Predictors of Escalation of Lipid-Lowering Therapy with Subanalysis of the Influence of Lipoprotein (a) on the Decision-Making Process. [PDF]

Diseases
Muszyński P, Dudzińska KN, Święcicka M, Grądzka-Matys W, Chlabicz M, Musiałowska D, Kruszyńska J, Kazberuk P, Bajda U, Tomaszuk-Kazberuk A.   +9 more
europepmc   +1 more source

Association of Ezetimibe and Statin Combinations With Recurrent Ischemic Stroke: A Nationwide Study With Dual Design. [PDF]

J Am Heart Assoc
Lee DH, Park YA, Choi SA, Kim JS, Yee J, Gwak HS.   +5 more
europepmc   +1 more source

Lipid-lowering therapy in Switzerland: time trends in utilization and cost, 2015-2023. [PDF]

Lipids Health Dis
Wolf S, Zufferey J, Kucher N, Lüscher TF, Barco S.   +4 more
europepmc   +1 more source